The 2015 Oncology Drug Pipeline: Innovation Drives the Race to Cure Cancer

被引：0
|
作者：
Buffery, Dalia [1 ]
机构：
[1] Amer Hlth & Drug Benefits, Cranbury, NJ 08512 USA
来源：
AMERICAN HEALTH AND DRUG BENEFITS | 2015年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：216 / 222
页数：7
相关论文
共 50 条
  • [1] Innovation Tops Current Trends in the 2016 Oncology Drug Pipeline
    Buffery, Dalia
    AMERICAN HEALTH AND DRUG BENEFITS, 2016, 9 (04): : 233 - 238
  • [2] Innovation in Oncology Drug Development
    Huber, Matthew
    Huber, Brian
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [3] Innovation drives orphan drug development
    Heemstra, Harald E.
    de Vrueh, Remco L. A.
    van Weely, Sonja
    Leufkens, Hubert G. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S137 - S138
  • [4] Challenges of urological oncology for cure of cancer
    Weissbach, L
    ONKOLOGIE, 2000, 23 (01): : 10 - 11
  • [5] Financing Drug Innovation: Cost versus Cure
    Antos, Joseph R.
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (03): : 125 - 126
  • [6] The Breakthrough Immunotherapy and the Race to Cure Cancer
    Simpkins, Carolyn Wong
    SCIENCE, 2018, 362 (6420) : 1254 - 1254
  • [7] THE BREAKTHROUGH Immunotherapy and the Race to Cure Cancer
    Swartz, Mimi
    NEW YORK TIMES BOOK REVIEW, 2019, 124 (02): : 17 - 17
  • [8] THE BREAKTHROUGH: IMMUNOTHERAPY AND THE RACE TO CURE CANCER
    Hlavka, Jakub P.
    HEALTH AFFAIRS, 2019, 38 (06) : 1052 - 1052
  • [9] Trends in oncology drug innovation in China
    Li, Guanqiao
    Qin, Yunhe
    Xie, Cuicui
    Wu, Yi-Long
    Chen, Xiaoyuan
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (01) : 15 - 16
  • [10] Trends in oncology drug innovation in China
    Guanqiao Li
    Yunhe Qin
    Cuicui Xie
    Yi-Long Wu
    Xiaoyuan Chen
    Nature Reviews Drug Discovery, 2021, 20 : 15 - 16
12345